Proteomics data of WHO I and WHO III meningiomas
PXD032342Deng et al., 2022
Overview
- Modality
- Proteomics (bulk MS)
- Sample count
- 10
- Patient count
- 10
- Institution
- Department of Neurosurgery, Beijing Tiantan Hospital / Beijing Neurosurgical Institute, Capital Medical University
- Corresponding author
- Shuyu Hao
- Platform
- TripleTOF 5600+
- Access type
- open
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- G1: 6 G2: 0 G3: 4
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
WHO grade breakdown availablePeer-reviewed
Publications
- Deng Y, et al. A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1. Frontiers in Oncology, 2022. PMID 35515130 · DOI
Related datasets
Also related: IPX0004219000
Sources
- proteomecentral.proteomexchange.orghttps://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD032342&outputMode=XML
- iprox.cnhttps://www.iprox.cn/page/project.html?id=IPX0004219000
- PubMedhttps://pubmed.ncbi.nlm.nih.gov/35515130/
- DOIhttps://doi.org/10.3389/fonc.2022.836257